Figure 3.
Effect of 3-(5’-Hydroxymethyl-2’-furyl)-1-benzyl indazole (YC-1) treatment on 2-h ischemia-induced BBB damage and MMP-2 induction. Rats received YC-1 at 24 h and 30 min before the onset of ischemia. Evan’s blue (EB) leakage (red) was seen in the ischemic region of interest 2 (ROI 2) after 2-h ischemia and in situ zymmography showed increased MMP-2 activity in the brain area where EB leakage occurred. Pretreatment with YC-1 significantly prevented MMP-2 induction as well as EB leakage. n = 3/group.
